4//SEC Filing
STEELE JOHN M 4
Accession 0001209191-18-013650
CIK 0000860730other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 7:34 PM ET
Size
24.5 KB
Accession
0001209191-18-013650
Insider Transaction Report
Form 4
STEELE JOHN M
SVP - Human Resources
Transactions
- Award
Common Stock
2018-02-22+17,600→ 73,236 total - Tax Payment
Common Stock
2018-02-22$100.54/sh−6,926$696,340→ 66,310 total - Exercise/Conversion
Common Stock
2018-02-25+2,272→ 68,582 total - Tax Payment
Common Stock
2018-02-25$100.84/sh−841$84,806→ 67,741 total - Award
Stock Appreciation Right
2018-02-22+4,125→ 4,125 totalExercise: $47.97From: 2018-02-22Exp: 2024-02-05→ Common Stock (4,125 underlying) - Exercise/Conversion
Restricted Stock Units
2018-02-25−1,008→ 0 totalExp: 2025-02-25→ Common Stock (1,008 underlying) - Exercise/Conversion
Restricted Stock Units
2018-02-25−1,264→ 1,264 totalExp: 2026-02-25→ Common Stock (1,264 underlying)
Holdings
- 6,751(indirect: By Trust)
Common Stock
- 13,501(indirect: By Trust)
Common Stock
- 7,222(indirect: By Trust)
Common Stock
- 30,835(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]On February 4, 2015, the reporting person was granted 8,800 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2015-2017. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2015-2017 earnings per share, the number of performance share units that vested equaled two times the units granted.
- [F2]Restricted stock units convert into common stock on a one-for-one basis.
- [F3]On February 5, 2014, the reporting person was granted 27,500 stock appreciation rights. The stock appreciation rights were eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. Based upon the Company's achievement with respect to the EBITDA performance criteria for 2017, 60% of the stock appreciation rights subject to such criteria vested, resulting in the vesting of 4,125 stock appreciation rights.
- [F4]On February 25, 2015, the reporting person was granted 2,015 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date.
- [F5]On February 25, 2016, the reporting person was granted 2,528 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date.
Issuer
HCA Healthcare, Inc.
CIK 0000860730
Entity typeother
Related Parties
1- filerCIK 0001269276
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 7:34 PM ET
- Size
- 24.5 KB